Hypolipidemic, antioxidant and anti-atherosclerogenic effect of aqueous extract leaves of Cassia. occidentalis Linn (Caesalpiniaceae) in diet-induced hypercholesterolemic rats

BMC Complementary and Alternative Medicine

Volumn 17, Issue 1, 2017, Pages

  Fidèle, Ntchapda ^a   Joseph, Barama ^a   Emmanuel, Talla ^a   Théophile, Dimo ^b  

^a UNIVERSITY OF NGAOUNDERE   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Anti atherosclerotic; Cassia occidentalis; Hypolipidemic; Lipid peroxidation TBARs

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CASSIA OCCIDENTALIS EXTRACT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT; CHOLESTEROL INTAKE; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIATHEROSCLEROGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD SAMPLING; BODY TEMPERATURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; FECES ANALYSIS; FLUID INTAKE; FOOD INTAKE; HEART WEIGHT; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC ACTIVITY; KIDNEY MASS; LIPID LIVER LEVEL; LIPID OXIDATION; LIVER TISSUE; LIVER WEIGHT; MALE; NONHUMAN; PHYTOCHEMISTRY; RAT; RAT MODEL; SENNA OCCIDENTALIS; TESTIS WEIGHT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ADVERSE EFFECTS; AFRICAN MEDICINE; ANIMAL; ATHEROSCLEROSIS; BLOOD; CHOLESTEROL INTAKE; DIET; DRINKING; DRUG EFFECTS; EATING; LIPID PEROXIDATION; LIVER; OXIDATIVE STRESS; PATHOLOGY; PHYTOTHERAPY; PLANT LEAF; PLAQUE, ATHEROSCLEROTIC; SENNA; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DIET; DRINKING; EATING; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC AGENTS; LIPID PEROXIDATION; LIPIDS; LIVER; MALE; MEDICINE, AFRICAN TRADITIONAL; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLAQUE, ATHEROSCLEROTIC; RATS, WISTAR; SENNA PLANT; WEIGHT GAIN;

EID: 85010411093     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-017-1566-x     Document Type: Article

References (46)

1. Li C, Zhang W, Zhou F, Chen C, Zhou L, Li Y, Liu L, Pei F, Luo H, Hu Z, Cai J, Zeng C. Cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia: a systematic review and meta-analysis. PLoS One. 2013;8:e77049.
2. Madubunyi II, Onoja SO, Asuzu IU. In vitro antioxidant and in vivo antidiabetic potential of the methanolic extract of Ficus glumosa Del (Moraceae) stem bark in alloxan-induced diabetic mice. Comp Clin Pathol. 2012;21:389-94.
3. World Health Organization. The tenth revision of the international classification of diseases and related health problems (ICD-10). Geneva: World Health Organization; 1992.
4. Capewell S, Ford E, Croft J, Critchley J, Greenlund K, Labarthe D. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ. 2010;88:120-30.
5. Vaessen S, Twisk J, Kastelein J, Kuivenhoven J. Gene Therapy in Disorders of Lipoprotein Metabolism. Curr Gene Ther. 2007;7:35-47.
6. Schwingshackl L, Hoffmann G. Comparison of the long-term effects of high-fat v. low-fat diet consumption on cardiometabolic risk factors in subjects with abnormal glucose metabolism: a systematic review and meta-analysis. Br J Nutr. 2014;111:2047-58.
7. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: ameta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-9.
8. Tsai TH, Tsai PJ, Ho SC. Antioxidant and anti-inflammatory activities of several commonly used spices. J Food Sci. 2005;70:93-7.
9. Hopkins PN, Stephenson S, Wu LL, Riley WA, Xin Y, Hunt SC. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 2001;87(5):547-53.
10. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J. 1997;18:1231-48.
11. Amano Y, Shimada M, Miura S, Adachi R, Tozawa R. Antidyslipidemic effects of a farnesoid X receptor antagonist in primates. Life Sci. 2014;106:25-31.
12. Leyes P, Martinez E, Larrousse M, Cofan M, Trabal J, Perez-Heras AM, et al. Effects of ezetimibe on cholesterol metabolism in HIV-infected patients with protease inhibitor associated dyslipidemia: a single-arm intervention trial. BMC Infect Dis. 2014;14:497.
13. Braunwald E. Heart disease. Philadelphia: Saunders company; 1997. Vol 3, pp. 1625.
14. Saraf S, Dixit VK, Tripathi SC, Patnaik GK. Antihepatotoxic Activity of Cassia occidentalis. Pharm Biol. 1994;32:178-83.
15. Samy RP, Ignacimuthu S. Antibacterial activity of some folklore medicinal plants used by tribals in Western Ghats of India. J Ethnopharmacol. 2000;69:63-71.
16. Tona L, Cimanga RK, Mesia K, Musuamba CT, De Bruyne T, Apers S, et al. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J Ethnopharmacol. 2004;93:27-32.
17. Ntchapda F, Barama J, Kemeta Azambou DR, Seke Etet PF, Dimo T. Diuretic and antioxidant activities of the aqueous extract of leaves of Cassia occidentalis (Linn.) in rats. Asian Pac J Trop Med. 2015;8(9):685-93. http://dx.doi.org/10.1016/j.apjtm.2015.07.030.
18. Trease GE, Evans MC. Textbook of pharmacognosy. Tindall: Bailliere; 1983.
19. Lal J, Gupta PC. Two new anthraquinones from the seeds of Cassia occidentalis. Experientia. 1974;30:850-1.
20. Purushotham KN, Annegowda HV, Sathish NK, Ramesh B, Mansor SM. Evaluation of phenolic content and antioxidant potency in various parts of Cassia auriculata L.: a traditionally valued plant. Pak J Biol Sci. 2014;17:41-8.
21. Alam N, Yoon KN, Lee TS. Antihyperlipidemic activities of Pleurotus ferulae on biochemical and histological function in hypercholesterolemic rats. JRMS. 2011;16(6):776-86.
22. Fatiha O, Rachid S, Nadia EG, Hakima B, Mustapha L, Souliman A, Noreddine G. Hypolipidemic and Anti-Atherogenic Effect of Aqueous Extract of Fennel (Foeniculum Vulgare) Extract in an Experimental Model of Atherosclerosis Induced by Triton WR-1339. Eur J Sci Res. 2011;52(1):91-9.
23. Akabue, Mittal. Hypolipidemic Activities of Dietary Pleurotus ostreatus in Hypercholesterolemic Rats. Microbiology. 1982;39:45-51.
24. Arbonnier M. Arbres arbustes et lianes des zones sèches d'Afrique de l'Ouest. France: CIRAD-MNHN-UICN; 2000. p. 462-63.
25. Friedewald W, Levy R, Fredrickson D. Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem. 1972;18:449-502.
26. Bonnefoy M, Abidi H, Jauffret M, Garcia I, Surrace J, Drai J. Hypocholesterolemia in hospitalized elderly: relations with inflammatory and nutritional status. Rev Med Interne. 2002;23:991-8.
27. Fassbender K, Lütjohann D, Dik MG, Bremmer M, König J, Walter S, Liu Y, Letièmbre M, von Bergmann K, Jonker C. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-the LASA study. Atherosclerosis. 2008;196(1):283-8. doi: 10.1016/j.atherosclerosis.2006.10.032.
28. Mohamed AR, El-Hadidy WF, Mannaa HF. Assessment of the prophylactic role of aspirin and/or clopidogrel on experimentally induced acute myocardial infarction in hypercholesterolemic rats. Drugs R D. 2014;14:233-9.
29. Bansal M, Jaswal S. Hypercholesterolemia Induced Oxidative Stress IsReduced in Rats with Diets Enriched with Supplement from Dunaliella salina. Am J Biomed Sci. 2009;1(81):196-204.
30. Catapano AL, Farnier M, Foody JM, Toth PP, Tomassini JE, Brudi P, et al. Combination therapy in dyslipidemia: Where are we now? Atherosclerosis. 2014;237:319-35.
31. Davidson MH, Voogt J, Luchoomun J, Decaris J, Killion S, Boban D, et al. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans. Atherosclerosis. 2013;230:322-9.
32. Terunuma S, Kumata N, Osada K. Ezetimibe impairs uptake of dietary cholesterol oxidation products and reduces alterations in hepatic cholesterol metabolism and antioxidant function in rats. Lipids. 2013;48:587-95.
33. Mathur R, Sharma A, Dixit VP, Varma M. Hypolipideamic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. J Ethnopharmacol. 1996;50:61-8.
34. Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism. 2007;56:444-50.
35. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-14.
36. Li L, Wang Y, Xu Y, Chen L, Fang Q, Yan X. Atorvastatin inhibits CD68 expression in aortic root through a GRP78-involved pathway. Cardiovasc Drugs Ther. 2014;28:523-32.
37. Sudhop T, Lutjohann D, Kodal A, Igel M, Tribble DL, Shah S, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 2002;106:1943-8.
38. Jain GC, Jhalani S, Agarwal S, Jain K. Hypolipidemic and Antiatherosclerotic Effect of Leptadenia pyrotechnica Extract in Cholesterol Fed Rabbits. Asian J Exp Sci. 2007;21(1):115-22.
39. Stein R, Littke R, Stax R, Welte DH. Quantity, provenance, and maturity of organic matter at ODP. Proc Ocean Drilling Program Sci Results Coll Stn. 1989;105:185-208. doi: 10.2973/odp.proc.sr.105.154.1989.
40. Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004;24(8):1367-73. Epub 2004 May 27.
41. Misra, Fridovich. Determination of the level of superoxide dismutase in whole blood. New Haven: Yale University Press; 1972. p. 101-9.
42. Midaoui AEL, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension. 2002;39(2):303-7.
43. Ntchapda F, Maguirgue K, Adjia H, Seke Etet PF, Dimo T. Hypolipidemic, antioxidant and anti-atherosclerogenic effects of the aqueous extract of Zanthoxylum heitzii stem bark in diet-induced hypercholesterolemic rats. Asian Pac J Trop Med. 2015;359-65. doi: 10.1016/S1995-7645(14)60344-8.
44. Al-Jaff FK. Effect of Coriander Seeds as Diet Ingredient on Blood Parameters of Broiler Chicks Raised under High Ambient Temperature. Int J Poult Sci. 2011;10(2):82-6. 82.
45. Gupta RK, Kesari AN, Diwakar S, Tyagi A, Tandon X, Chandra R, Watal G. In vivo evaluation of anti-oxidant and anti-lipidemic potential Annona squamosa aqueous extract in Type 2 diabetic models. J Ethnopharmacol. 2008;1016(10):3-8.
46. Patil R, Prakash K, Maheshwari L. Hypolipidemic Effect of Celastrus paniculatus in Experimentally Induced Hypercholesterolemic Wistar Rats. Indian J Clin Biochem. 2010;25(4):405-10.